Windtree Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Windtree Therapeutics

15/11/2021 22:01

* Windtree Therapeutics Inc  WINT.OQ  reported a quarterly
adjusted loss of 31 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 29 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Windtree Therapeutics Inc's reported EPS for the quarter was a
loss of 31 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Windtree Therapeutics Inc shares had fallen by 13.6% this
quarter and lost 65.3% so far this year.
* The company reported a quarterly loss of $8.21 million.
* Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $8.25 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 15 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated